TRAP1 and colorectal carcinoma: To this aim, BRAF-V600E and BRAF-wt CRC cells were exposed to sub-cytotoxic concentrations of the HSP90/TRAP1 dual inhibitor gamitrinib and evaluated for cell viability (Figure 7A), apoptotic cell death (Figure 7B) and colony/foci formation (Figure 7C).